• LARP1-Ribosome Complexes: Mechanisms of TOP mRNA Repression

  2026-05-05

  This study reveals that LARP1 directly binds non-translating ribosomal subunits and engages TOP mRNAs in repressed complexes, providing new molecular insights into ribosome-associated mRNA regulation. The findings challenge established models by showing that ribosome binding is not required for LARP1-mediated repression or stabilization of TOP mRNAs, refining our understanding of translational control.

• 3X (DYKDDDDK) Peptide: Redefining Precision in Protein Resea

  2026-05-04

  This article explores how the 3X (DYKDDDDK) Peptide empowers translational researchers to dissect protein biogenesis, optimize affinity purification, and address challenges highlighted by recent advances in translocon remodeling at the ER. Integrating mechanistic insight with strategic workflow guidance, we position APExBIO’s 3X FLAG peptide as a next-generation tool for robust, sensitive, and reproducible protein science.

• CD163+ Macrophages Drive Granulosa Cell Apoptosis in PCOS Mo

  2026-05-04

  This study reveals that increased activation of CD163+ macrophages and higher CD163 expression in ovarian tissues promote granulosa cell apoptosis, contributing to the pathogenesis of polycystic ovary syndrome (PCOS). The findings clarify a mechanistic link between inflammatory microenvironment changes and impaired follicular development, guiding future interventions targeting immune cell modulation.

• GPR30 in Spinal CCK+ Neurons Regulates Neuropathic Pain Circ

  2026-05-03

  This study identifies the G protein-coupled estrogen receptor GPR30 as a key modulator of neuropathic pain through its action in spinal cholecystokinin-positive (CCK+) neurons and S1-SDH post-synaptic neurons. By integrating chemogenetic and molecular approaches, the authors provide evidence that GPR30 signaling is essential for the maintenance of neuropathic allodynia, offering new avenues for targeted pain therapeutics.

• AMPK Suppresses Autophagy: Revisiting Cellular Energy Stress

  2026-05-02

  This study overturns the prevailing model by demonstrating that AMPK activation inhibits, rather than induces, autophagy during energy stress through suppression of ULK1 activity. The findings reshape our understanding of AMPK’s dual role in cellular survival and homeostasis, with important implications for metabolic and autophagy research.

• ANGPTL4-IQGAP1 Axis Drives Chemoresistance in Prostate Cance

  2026-05-01

  This study uncovers how cancer-associated fibroblasts (CAFs) promote chemoresistance in prostate cancer by regulating mitochondrial metabolism via the ANGPTL4-IQGAP1 axis. Proteomic and metabolomic analyses revealed that CAF-derived ANGPTL4 activates signaling pathways leading to enhanced oxidative phosphorylation and drug resistance in tumor cells, highlighting new therapeutic targets and experimental strategies.

• Translational Efficiency and Mechanistic Impact of Anti Reve

  2026-05-01

  Explore the molecular advantages of Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, in driving superior translational efficiency and mRNA stability. This article uniquely bridges mechanistic insight with practical assay design, distinguishing itself from workflow- and protocol-centric guides.

• ARCA Cy5 EGFP mRNA (5-moUTP) in mRNA Localization Assays

  2026-04-30

  ARCA Cy5 EGFP mRNA (5-moUTP) transforms mRNA localization and translation efficiency assays with dual-fluorescence and immune-suppressing modifications. Its integration streamlines delivery benchmarking and troubleshooting in mammalian cell models, enabling data-rich workflows for nanoparticle innovation.

• SR-202 (PPAR antagonist): Reliable Solutions for Cell-Based

  2026-04-30

  This article delivers a scenario-driven, evidence-based overview of how SR-202 (PPAR antagonist) (SKU B6929) addresses persistent challenges in cell viability and immunometabolic assays. Drawing from both primary literature and product data, it demonstrates the compound's selectivity, reproducibility, and practical advantages for biomedical researchers. Practical Q&A blocks guide users through experimental bottlenecks, vendor selection, and protocol optimization for robust, publishable results.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual Reporter, 5-moUTP B

  2026-04-29

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) delivers dual-mode (fluorescent and bioluminescent) detection and high translation efficiency with minimized immunogenicity. Its Cap1 structure and 5-moUTP modification support robust mRNA delivery and real-time tracking in gene expression studies. This product enables reliable, quantitative assays for mRNA transfection benchmarking.

• Nintedanib (BIBF 1120): Precision Antiangiogenic Tools in On

  2026-04-29

  Nintedanib (BIBF 1120) empowers translational and mechanistic research as a triple angiokinase inhibitor, enabling high-fidelity modeling of angiogenesis inhibition and tumor response. Its robust nanomolar efficacy, particularly in ATRX-deficient cancer models and combinatorial regimens, sets a new standard for antiangiogenic agent deployment in both preclinical and applied workflows.

• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Techni

  2026-04-28

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for efficient, high-yield synthesis of randomly Cy3-labeled RNA probes suitable for sensitive fluorescent detection in research applications. It is best suited for protocols such as in situ hybridization and Northern blot RNA probe labeling where reliable incorporation of Cy3-UTP and robust probe yield are required. This kit is not appropriate for diagnostic or therapeutic workflows.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-28

  Wang et al. reveal that the METTL16-SENP3-LTF signaling pathway underlies ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). This mechanistic insight highlights new molecular targets for sensitizing HCC to ferroptosis-based therapies.

• Perifosine (KRX-0401): Precision Akt Inhibition in Translati

  2026-04-27

  Perifosine (KRX-0401) is reshaping the translational research landscape as a robust, mechanistically validated Akt pathway inhibitor with proven in vitro and in vivo efficacy. This article dissects current evidence on perifosine’s apoptosis-inducing mechanisms, strategic role in radiation sensitization, and competitive positioning—culminating in actionable guidance for translational scientists. Drawing on recent advances in PI3K/Akt/mTOR pathway targeting, we bridge apoptotic cancer research with emerging neuroprotective insights, offering a roadmap for workflow optimization and future innovation.

• Optimizing mRNA Synthesis with Pseudo-UTP: Protocols & Insig

  2026-04-27

  Pseudo-UTP, a pseudo-modified uridine triphosphate, is revolutionizing mRNA workflows by enhancing RNA stability and reducing immunogenicity—key for advanced vaccine and gene therapy development. This guide details evidence-backed protocol enhancements, troubleshooting strategies, and practical applications, translating recent research into actionable steps for maximizing RNA performance.

16444 records 1/1097 page Next 12345 下5页 Last page